BLIFASEND Trademark

Trademark Overview


On Wednesday, March 26, 2025, a trademark application was filed for BLIFASEND with the United States Patent and Trademark Office. The USPTO has given the BLIFASEND trademark a serial number of 99105159. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, August 8, 2025. This trademark is owned by Glaxo Group Limited. The BLIFASEND trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases
blifasend

General Information


Serial Number99105159
Word MarkBLIFASEND
Filing DateWednesday, March 26, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, August 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Wednesday, March 26, 2025NEW APPLICATION ENTERED
Wednesday, March 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 8, 2025LETTER OF SUSPENSION E-MAILED
Friday, August 8, 2025SUSPENSION LETTER WRITTEN
Friday, August 8, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 14, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 26, 2025APPLICATION FILING RECEIPT MAILED
Thursday, August 7, 2025ASSIGNED TO EXAMINER